News
Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event Authors: Malvi Thakker, MD [email protected], Kalimullah Quadri, MD, Ankuri Desai, MD, Wajiha ...
Provided by PR Newswire Mar 17, 2025, 4:00:00 AM Rona Therapeutics Receives IND Clearance from FDA to Initiate Phase 2 Study of RN0361: an APOC3 Targeted siRNA for Management of Hypertriglyceridemia ...
Pembrolizumab and Severe Hypertriglyceridemia Requiring Apheresis: An Immune-Related Adverse Event Authors: Malvi Thakker, MD [email protected], Kalimullah Quadri, MD, Ankuri Desai, MD, Wajiha ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback